[Refractory idiopathic cold agglutinin disease successfully treated with intermittent high-dose cyclophosphamide].
A 56-year-old woman, who had been suffering from idiopathic cold agglutinin disease and treated unsuccessfully with prednisolone and cyclosporine A for 6 months, was referred to our hospital in November 1998. She was given methylprednisolone pulse therapy followed by low-dose cyclophosphamide, but her anemia did not improve. We then began administration of intermittent high-dose cyclophosphamide (1,200 mg/day, every 4 weeks), and this resulted in a dramatic increase of her hemoglobin level and improvement of her symptoms. She is currently receiving 500 mg of cyclophosphamide every 2 months and showing a good response. Intermittent high-dose cyclophosphamide therapy can be an effective treatment for refractory cold agglutinin disease.
Nakagawa
M
M
Department of Internal Medicine, Kushiro-Rosai Hospital.
Miyagishima
T
T
Kamata
T
T
Arai
S
S
Miura
Y
Y
Onishi
S
S
Kishimoto
A
A
Kamishima
Y
Y
Choi
G H
GH
Kudo
M
M
Okabe
M
M
D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008875:Middle Aged; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide